Design of short-sequenced collagen type III-derived peptides with GPR56 dependent biological activity
Bioscience Reports · 18.11.2026 · 46 (11)
DOI: 10.1042/bsr20250320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 03.11.2026. Verfasst von Israa Mohammed Al-Amily und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Malmö, Division of Islet Cell Physiology, University of Lund, Sweden. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Collagen Type III, Insulin-Secreting Cells, Peptides. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Mats Paulsson foundation.
Abstract (Originalsprache)
We have previously shown that activation of G protein-coupled receptor 56 (GPR56) by its endogenous ligand collagen type III (Coll III) improves pancreatic β-cell function and potentiates glucose-stimulated insulin secretion (GSIS). In the present study, alignment of Coll III and GPR56 genomic DNA revealed three complementary nucleotide regions, enabling the design of three short peptides (NQGCKL·NH2, H·LLSSR·NH2, and NH2·GYYCG·COOH). The peptides in double or triple combinations markedly increased cellular cAMP levels, enhanced GSIS, and improved cell viability both in human (EndoC βH1 cells) and rat pancreatic β-cell lines (INS-1 832/13 cells). These effects were markedly absent in GPR56-knockdown cells, supporting receptor-dependent specificity. The peptide mixtures also counteracted cytokine- and glucotoxicity-induced cellular stress, restoring cAMP generation and insulin secretion. Comparable effects were not observed with dapagliflozin, while glibenclamide decreased cell viability under similar conditions. In hepatic cell lines (HepG2 and Hep1–6), peptide combinations enhanced cell survival in a GPR56-dependent manner, consistent with a broader role of GPR56 in metabolic regulation. Collectively, the data identify three short sequence collagen III-derived peptides whose biological effects are dependent on GPR56 expression and support their further investigation as tools for studying GPR56-associated cellular signaling for the future in vivo validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Science, Malmö, Division of Islet Cell Physiology, University of Lund, Sweden.
- Department of Clinical Science, Malmö, Division of Experimental Cardiovascular Research, University of Lund, Sweden.
ORCID-Profile: Albert Salehi
Förderung
- Swedish Research Council
- Mats Paulsson foundation
Zitieren
APA
Mohammed Al-Amily, I., Parandeh, F., Dunér, P., Sjögren, M., & Salehi, A. (2026). Design of short-sequenced collagen type III-derived peptides with GPR56 dependent biological activity. Bioscience Reports, 46(11). https://doi.org/10.1042/bsr20250320
Vancouver
Mohammed Al-Amily I, Parandeh F, Dunér P, Sjögren M, Salehi A. Design of short-sequenced collagen type III-derived peptides with GPR56 dependent biological activity. Bioscience Reports. 2026;46(11). doi:10.1042/bsr20250320
BibTeX
@article{MohammedAlAmily2026,
author = {Mohammed Al-Amily, Israa and Parandeh, Fariborz and Dunér, Pontus and Sjögren, Marie and Salehi, Albert},
title = {Design of short-sequenced collagen type III-derived peptides with GPR56 dependent biological activity},
journal = {Bioscience Reports},
year = {2026},
volume = {46},
number = {11},
doi = {10.1042/bsr20250320}
}
EUVIMED